Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
PRIORITY PRESS - American Heart Association 2011 Scientific Sessions
Pulmonary Arterial Hypertension: Addressing the Challenge of Early Diagnosis and Treatment
Orlando, Florida / November 12-16, 2011
Orlando - As initial symptoms are non-specific, early diagnosis of pulmonary arterial hypertension (PAH) is challenging. Echocardiography is the best screening tool but a definitive right heart catheterization should not be delayed as early...
PHYSICIAN PERSPECTIVE - American Heart Association (AHA) Scientific Sessions 2011
AIM-HIGH Study: Evaluating Results in the Context of the HDL-C Hypothesis
Orlando, Florida / November 12-16, 2011
Guest Editor: Ruth McPherson, MD, FRCPCDirector, Atherogenomics Laboratoryand Lipid ClinicProfessor of Medicine and BiochemistryUniversity of Ottawa Heart Institute Ottawa, Ontario Introduction There is a compelling rationale for...
PRIORITY PRESS - Canadian Cardiovascular Congress
HDL-C Mechanisms for CV Risk Management: Quality over Quantity
Vancouver, British Columbia / October 22-26, 2011
Vancouver - Presentations here at the 2011 CCC demonstrated that the HDL-C hypothesis is set to be retested. The new-generation agents for raising HDL-C are not only capable of proving that it is a targetable risk factor but will also help...
PRIORITY PRESS - Canadian Cardiovascular Congress 2011
Canadian Interventional Cardiology Guidelines Recognizing Outcome Benefits of Newer Antiplatelet Strategies
Vancouver, British Columbia / October 22-26, 2011
Vancouver - New guidelines in Canada and Europe have been issued to identify where the new P2Y12 inhibitors can be employed in the management of acute coronary syndromes (ACS) to improve outcomes. In the phase III trials that brought these...
PRIORITY PRESS - Canadian Society of Internal Medicine 2011
Managing Overall Cardiovascular Risk in Patients
Halifax, Nova Scotia / October 12-15, 2011
Halifax - General internists in Canada are often required to manage patients with a wide variety of diseases and multiple risk factors for cardiovascular (CV) disease. At this year’s CSIM meeting, overviews of treatment and risk management...
PRIORITY PRESS - 2011 Canadian Hypertension Congress Annual Scientific Meeting
Dual Therapy Recommendations in Hypertension: Progress with a Single-pill Combination
Alliston, Ontario / October 2-5, 2011
Chief Medical Editor: Dr. Léna Coïc, Montréal, Quebec As discussed here at the CHC by Dr. George Dresser, Associate Professor of Medicine, University of Western Ontario, London, most patients require at least 2 drugs to...
PRIORITY PRESS - 2011 Canadian Hypertension Congress Annual Scientific Meeting
Advancing Hypertension Therapy: Single-pill Combinations, Better Tolerated ß-Blockers
Alliston, Ontario / October 2-5, 2011
Chief Medical Editor: Dr. Léna Coïc, Montréal, Quebec The Canadian Hypertension Education Program (CHEP) guidelines indicate that lifestyle modification is a primary goal for the treatment of hypertensive adults without...
PRIORITY PRESS - 21st Annual Congress of the European Respiratory Society
Early Diagnosis Key to Improving Long-term Outcomes in Patients with Pulmonary Arterial Hypertension
Amsterdam, The Netherlands / September 24-28, 2011
Amsterdam - The benefits of treating pulmonary arterial hypertension (PAH) at an early stage of the disease have been clearly demonstrated and are supported by current treatment guidelines. PAH patients in NYHA/WHO functional class (FC) II...
PRIORITY PRESS - 47th Annual Meeting of the European Association for the Study of Diabetes (EASD)
New Targets for Glycemic Control in the Treatment of Type 2 Diabetes Mellitus
Lisbon, Portugal / September 12-16, 2011
Chief Medical Editor: Dr. Léna Coïc, Montréal, Quebec According to Dr. Peter Rossing, Chief Physician and Head of Research, Steno Diabetes Center, Gentofte, Denmark, in type 2 diabetes, progressive ß-cell...